170 jobs lost as pharmaceutical company closes Laval plant
Another blow to the local pharmaceutical industry.
Pharmaceutical giant Boehringer-Ingelheim will be closing its research facility in Laval in early 2013, throwing about 170 people out of work.
The ones who'll lose their jobs will be mainly research scientists who specialize in studying infectious diseases such as HIV and Hepatitis C.
The company is blaming shifting priorities for the decision to shut down.
The company spent $36 million to upgrade the Laval facility four years ago.